Next Article in Journal
A Comprehensive Evaluation of Studies on the Adverse Effects of Medications in Australian Aged care Facilities: A Scoping Review
Next Article in Special Issue
The Development of an Accreditation Framework for Continuing Education Activities for Pharmacists
Previous Article in Journal
Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies
Previous Article in Special Issue
Assessing Performance and Engagement on a Computer-Based Education Platform for Pharmacy Practice
Open AccessArticle

A Continuing Professional Development Program for Pharmacists Implementing Pharmacogenomics into Practice

1
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada
2
Pharmacy Services, Women’s College Hospital, Toronto, ON M5S 1B2, Canada
3
Pharmacy Services, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, Canada
4
Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada
5
Department of Family and Community Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada
6
Women’s College Research Institute, Women’s College Hospital, Toronto, ON M5S 1B2, Canada
*
Author to whom correspondence should be addressed.
Pharmacy 2020, 8(2), 55; https://doi.org/10.3390/pharmacy8020055
Received: 28 January 2020 / Revised: 28 February 2020 / Accepted: 13 March 2020 / Published: 28 March 2020
(This article belongs to the Special Issue Continuing Professional Development in Pharmacy)
A continuing professional development (CPD) program for pharmacists practicing in community and team-based primary care settings was developed and evaluated using Moore’s framework for the assessment of continuing medical education. The program had three components: online lectures, a two-day training workshop, and patient case studies. Knowledge (pre-post multiple choice test); attitudes, readiness, and comfort with applying pharmacogenomics in their practices (pre-post surveys); and experiences of implementing pharmacogenomics in practice (semi-structured interviews) were assessed. Twenty-one of 26 enrolled pharmacists successfully completed the program, and were satisfied with their experience. Almost all achieved a score of 80% or higher on the post-training multiple choice test, with significantly improved scores compared to the pre-training test. Pre- and post-training surveys demonstrated that participants felt that their knowledge and competence increased upon completion of the training. In the follow-up, 15 pharmacists incorporated pharmacogenomics testing into care for 117 patients. Ten pharmacists participated in semi-structured interviews, reporting strong performance in the program, but some difficulty implementing new knowledge in their practices. This multi-component CPD program successfully increased pharmacists’ knowledge, readiness, and comfort in applying pharmacogenomics to patient care in the short-term, yet some pharmacists struggled to integrate this new service into their practices. View Full-Text
Keywords: pharmacogenomics; pharmacists; pharmacy; continuing professional development; continuing education pharmacogenomics; pharmacists; pharmacy; continuing professional development; continuing education
Show Figures

Figure 1

MDPI and ACS Style

Crown, N.; Sproule, B.A.; Luke, M.J.; Piquette-Miller, M.; McCarthy, L.M. A Continuing Professional Development Program for Pharmacists Implementing Pharmacogenomics into Practice. Pharmacy 2020, 8, 55.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop